|
Post by healthy11 on May 31, 2017 9:39:08 GMT -5
www.news-medical.net/news/20170526/Clinical-study-tests-100-year-old-drug-in-children-with-autism-spectrum-disorder.aspxIn the Annals of Clinical and Translational Neurology, first author Robert K. Naviaux, MD, PhD, professor of medicine, pediatrics and pathology at UC San Diego School of Medicine and colleagues describe a novel double-blind, placebo-controlled safety study involving 10 boys, ages 5 to 14 years, all diagnosed with ASD. Five of the 10 boys received a single, intravenous infusion of suramin, a drug originally developed in 1916 to treat trypanosomiasis (sleeping sickness) and river blindness, both caused by parasites. The other five boys received a placebo. The trial followed earlier testing in a mouse model of autism in which a single dose of suramin temporarily reversed symptoms of the neurological disorder. The results in humans were equally notable...All five boys who received the suramin infusion displayed improvements in language and social behavior, restricted or repetitive behaviors and coping skills.
|
|